promising results of cabozantinib plus nivolumab in non-clear cell rcc
Published 1 year ago • 199 plays • Length 1:20Download video MP4
Download video MP3
Similar videos
-
1:06
promising tki-ici combinations for non-clear cell rcc
-
0:54
phase ib/ii trial of 177lu-girentuximab with cabozantinib and nivolumab in clear cell rcc
-
3:58
nivolumab plus cabozantinib for patients with non-clear cell renal cell carcinoma
-
5:05
cabozantinib plus atezolizumab for non-clear cell renal cell carcinoma
-
3:29
emerging roles of nivolumab and cabozantinib for renal cell carcinoma
-
1:28
keynote-b61: first-line lenvatinib pembrolizumab in non-clear cell rcc
-
1:26
neoadjuvant cabozantinib in patients with locally advanced non-metastatic ccrcc
-
5:00
keynote-b61: putting a focus on non-clear cell rcc treatment
-
1:23
checkmate 9er: nivolumab with cabozantinib in renal cell carcinoma
-
4:22
cabozantinib in combination w/ nivolumab and ipilimumab of imdc intermediate or poor risk signif...
-
0:51
dr. sznol discusses immunotherapy in non-clear cell renal cancer
-
1:40
phase iii meteor trial: cabozantinib vs everolimus for advanced clear cell renal cell carcinoma
-
5:58
checkmate 9er update confirms benefits of nivolumab–cabozantinib in rcc | cristina suárez
-
1:49
cosmic-313: cabozantinib with nivolumab and ipilimumab in untreated arcc
-
1:10
dr. mcdermott on the promise of pembrolizumab in non-clear cell rcc
-
6:16
treatment-free survival results of nivolumab and salvage nivolumab ipilimumab for accrcc
-
2:38
checkmate 9er: cabo-nivo superior to sunitinib in extended follow-up results
-
6:37
cabozantinib in combination with nivolumab demonstrated continued survival and hrqol in arcc pat...
-
0:51
dr. pal on the safety profile of cabozantinib/atezolizumab in advanced rcc